SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001193125-16-628862
Filing Date
2016-06-22
Accepted
2016-06-22 15:39:06
Documents
6
Period of Report
2016-07-27
Effectiveness Date
2016-06-22

Document Format Files

Seq Description Document Type Size
1 DEF 14A d84052ddef14a.htm DEF 14A 701356
2 GRAPHIC g84052g09k10.jpg GRAPHIC 6741
3 GRAPHIC g84052g32i96.jpg GRAPHIC 29583
4 GRAPHIC g84052g48u91.jpg GRAPHIC 29961
5 GRAPHIC g84052g75d29.jpg GRAPHIC 43130
6 GRAPHIC g84052g80q04.jpg GRAPHIC 796
  Complete submission text file 0001193125-16-628862.txt   854653
Mailing Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110
Business Address 33 ARCH STREET SUITE 3110 BOSTON MA 02110 617-639-1500
JUNIPER PHARMACEUTICALS INC (Filer) CIK: 0000821995 (see all company filings)

IRS No.: 592758596 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-10352 | Film No.: 161726584
SIC: 2834 Pharmaceutical Preparations